Susquehanna International Group
MRKR icon

Susquehanna International Group’s Marker Therapeutics MRKR Stock Holding History

Susquehanna International Group’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,780
Closed -$12K – 13779
2022
Q2 		$12K Hold
3,780
– – ﹤0.01% 12477
2022
Q1 		$17K Buy
3,780
+2,450
+184% +$14K ﹤0.01% 12666
2021
Q4 		$13K Sell
1,330
-6,870
-84% -$91.2K ﹤0.01% 12897
2021
Q3 		$139K Sell
8,200
-14,630
-64% -$300K ﹤0.01% 11846
2021
Q2 		$637K Buy
22,830
+9,320
+69% +$245K ﹤0.01% 8976
2021
Q1 		$303K Buy
13,510
+11,240
+495% +$257K ﹤0.01% 10585
2020
Q4 		$33K Sell
2,270
-810
-26% -$12.6K ﹤0.01% 10828
2020
Q3 		$46K Buy
3,080
+600
+24% +$10.9K ﹤0.01% 10220
2020
Q2 		$51K Buy
+2,480
New +$54.2K ﹤0.01% 9746
2019
Q4 		– Sell
-10,390
Closed -$531K – 10289
2019
Q3 		$531K Buy
10,390
+8,620
+487% +$509K ﹤0.01% 7167
2019
Q2 		$140K Buy
+1,770
New +$105K ﹤0.01% 9421
2019
Q1 		– Sell
-1,080
Closed -$60K – 9467
2018
Q4 		$60K Buy
1,080
+30
+3% +$2.19K ﹤0.01% 8416
2018
Q3 		$95K Buy
+1,050
New +$90.1K ﹤0.01% 8625

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Susquehanna International Group's MRKR Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Marker Therapeutics (MRKR) in Q1 2026: 48,780 shares worth $63.4K. The stake represents ﹤0.01% of the portfolio and ranks #12553 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in MRKR as recently as Q2 2025.

Susquehanna International Group first reported a position in MRKR in Q4 2018 and has held it in 19 quarters since. The position peaked at $505K in Q1 2019. 35 funds tracked by Wall St. Rank hold MRKR as of Q1 2026.

  • Susquehanna International Group held 48,780 shares of Marker Therapeutics worth $63.4K as of Q1 2026.
  • Marker Therapeutics was a new Susquehanna International Group position in Q1 2026.
  • Marker Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12553 holding.
  • Susquehanna International Group first reported a position in Marker Therapeutics in Q4 2018 and has held it in 19 quarters since.
  • Susquehanna International Group's Marker Therapeutics position peaked at $505K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.